Investor mix
15 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 73% |
| Private equity | 2 | 13% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 1 | 7% |
Therapies for the treatment of hematology and oncology disorders
15 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 73% |
| Private equity | 2 | 13% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 1 | 7% |